J 2023

Systematic Approach Revealed SERPING1 Splicing-Affecting Variants to be Highly Represented in the Czech National HAE Cohort

GROMBIŘÍKOVÁ, Hana, Viktor BÍLY, Přemysl SOUČEK, Michal KRAMÁREK, Roman HAKL et. al.

Basic information

Original name

Systematic Approach Revealed SERPING1 Splicing-Affecting Variants to be Highly Represented in the Czech National HAE Cohort

Authors

GROMBIŘÍKOVÁ, Hana (203 Czech Republic, belonging to the institution), Viktor BÍLY (703 Slovakia, belonging to the institution), Přemysl SOUČEK (203 Czech Republic, belonging to the institution), Michal KRAMÁREK (703 Slovakia, belonging to the institution), Roman HAKL (203 Czech Republic, belonging to the institution), Lucie BALLONOVÁ (203 Czech Republic, belonging to the institution), Barbora RAVCUKOVA, Dita RICNA, Karolína KOŽENÁ (203 Czech Republic, belonging to the institution), Lucie KRATOCHVÍLOVÁ (203 Czech Republic), Marta SOBOTKOVA (203 Czech Republic), Radana ZACHOVA (203 Czech Republic), Pavel KUKLÍNEK (203 Czech Republic, belonging to the institution), Pavlina KRALICKOVA (203 Czech Republic), Irena KRCMOVA (203 Czech Republic), Jana HANZLIKOVA (203 Czech Republic), Martina VACHOVA (203 Czech Republic), Olga KRYSTUFKOVA (203 Czech Republic), Eva DANKOVA (203 Czech Republic), Milos JESENAK (703 Slovakia), Martina NOVACKOVA (203 Czech Republic), Michal SVOBODA (203 Czech Republic), Jiří LITZMAN (203 Czech Republic, belonging to the institution) and Tomáš FREIBERGER (203 Czech Republic, belonging to the institution)

Edition

Journal of Clinical Immunology, NEW YORK, SPRINGER, 2023, 0271-9142

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30102 Immunology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 9.100 in 2022

RIV identification code

RIV/00216224:14110/23:00132410

Organization unit

Faculty of Medicine

UT WoS

001063524100001

Keywords in English

HAE; C1-INH-HAE; hereditary angioedema; SERPING1; splicing genotype–phenotype relationship; time to diagnosis

Tags

International impact, Reviewed
Změněno: 8/7/2024 13:57, Mgr. Michal Petr

Abstract

V originále

Hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) is a rare and life-threatening condition characterized by recurrent localized edema. We conducted a systematic screening of SERPING1 defects in a cohort of 207 Czech patients from 85 families with C1-INH-HAE. Our workflow involved a combined strategy of sequencing extended to UTR and deep intronic regions, advanced in silico prediction tools, and mRNA-based functional assays. This approach allowed us to detect a causal variant in all families except one and to identify a total of 56 different variants, including 5 novel variants that are likely to be causal. We further investigated the functional impact of two splicing variants, namely c.550 + 3A > C and c.686-7C > G using minigene assays and RT-PCR mRNA analysis. Notably, our cohort showed a considerably higher proportion of detected splicing variants compared to other central European populations and the LOVD database. Moreover, our findings revealed a significant association between HAE type 1 missense variants and a delayed HAE onset when compared to null variants. We also observed a significant correlation between the presence of the SERPING1 variant c.-21 T > C in the trans position to causal variants and the frequency of attacks per year, disease onset, as well as Clinical severity score. Overall, our study provides new insights into the genetic landscape of C1-INH-HAE in the Czech population, including the identification of novel variants and a better understanding of genotype–phenotype correlations. Our findings also highlight the importance of comprehensive screening strategies and functional analyses in improving the C1-INH-HAE diagnosis and management.

Links

MUNI/A/1098/2022, interní kód MU
Name: Nespecifická imunita u chorob imunitního systému
Investor: Masaryk University, Non-specific immunity in immune system diseases
NV18-05-00330, research and development project
Name: Genetická determinace závažnosti otoků podmíněných bradykininem u pacientů s hereditárním angioedémem
Investor: Ministry of Health of the CR, Genetic determination of bradykinin-mediated angioedema severity in patients with hereditary angioedema